Lupus Landmark Study: A Prospective Registry and Biorepository
Lupus Nephritis | Systemic Lupus Erythematosus (SLE) | Neuropsychiatric Systemic Lupus ErythematosusThe purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
* Able to understand and comply with study procedures and voluntarily sign a written informed consent document
* Age 18 years or older at the time of enrollment
* Fulfill criteria for SLE based on one or more of the following classifications systems:
Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment.
Exclusion Criteria:
* Not able to obtain consent
* Not able to meet protocol visit requirements
* Pregnant at the time of enrollment
Study Location
University of Calgary
University of CalgaryCalgary, Alberta
Canada
Contact Study Team
University of Manitoba
University of ManitobaWinnipeg, Manitoba
Canada
Contact Study Team
CHU de Québec - Université Laval
CHU de Québec - Université LavalQuebec City, Quebec
Canada
Contact Study Team
University Health Network/Toronto Western Hospital
University Health Network/Toronto Western HospitalToronto, Ontario
Canada
Contact Study Team
CHU de Québec - Université Laval
CHU de Québec - Université LavalQuébec, Quebec
Canada
Contact Study Team
McGill University Health Centre
McGill University Health CentreMontreal, Quebec
Canada
Contact Study Team
- Study Sponsored By
- Lupus Research Alliance
- Participants Required
- More Information
- Study ID:
NCT05934149